192 related articles for article (PubMed ID: 11506112)
1. A new model of electrically evoked pain and hyperalgesia in human skin: the effects of intravenous alfentanil, S(+)-ketamine, and lidocaine.
Koppert W; Dern SK; Sittl R; Albrecht S; Schüttler J; Schmelz M
Anesthesiology; 2001 Aug; 95(2):395-402. PubMed ID: 11506112
[TBL] [Abstract][Full Text] [Related]
2. Effects of intravenous ketamine, alfentanil, or placebo on pain, pinprick hyperalgesia, and allodynia produced by intradermal capsaicin in human subjects.
Park KM; Max MB; Robinovitz E; Gracely RH; Bennett GJ
Pain; 1995 Nov; 63(2):163-172. PubMed ID: 8628581
[TBL] [Abstract][Full Text] [Related]
3. Differential modulation of remifentanil-induced analgesia and postinfusion hyperalgesia by S-ketamine and clonidine in humans.
Koppert W; Sittl R; Scheuber K; Alsheimer M; Schmelz M; Schüttler J
Anesthesiology; 2003 Jul; 99(1):152-9. PubMed ID: 12826855
[TBL] [Abstract][Full Text] [Related]
4. Concentration-effect relationship of intravenous alfentanil and ketamine on peripheral neurosensory thresholds, allodynia and hyperalgesia of neuropathic pain.
Leung A; Wallace MS; Ridgeway B; Yaksh T
Pain; 2001 Mar; 91(1-2):177-87. PubMed ID: 11240090
[TBL] [Abstract][Full Text] [Related]
5. Analgesic and cognitive effects of intravenous ketamine-alfentanil combinations versus either drug alone after intradermal capsaicin in normal subjects.
Sethna NF; Liu M; Gracely R; Bennett GJ; Max MB
Anesth Analg; 1998 Jun; 86(6):1250-6. PubMed ID: 9620514
[TBL] [Abstract][Full Text] [Related]
6. Interaction of physostigmine and alfentanil in a human pain model.
Wehrfritz AP; Ihmsen H; Schmidt S; Müller C; Filitz J; Schüttler J; Koppert W
Br J Anaesth; 2010 Mar; 104(3):359-68. PubMed ID: 20047897
[TBL] [Abstract][Full Text] [Related]
7. Studies with ketamine and alfentanil following Freund's complete adjuvant-induced inflammation in rats.
Edwards SR; Mather LE; Smith MT
Clin Exp Pharmacol Physiol; 2007; 34(5-6):414-20. PubMed ID: 17439409
[TBL] [Abstract][Full Text] [Related]
8. Cold allodynia and hyperalgesia in neuropathic pain: the effect of N-methyl-D-aspartate (NMDA) receptor antagonist ketamine--a double-blind, cross-over comparison with alfentanil and placebo.
Jørum E; Warncke T; Stubhaug A
Pain; 2003 Feb; 101(3):229-235. PubMed ID: 12583865
[TBL] [Abstract][Full Text] [Related]
9. Differential effects of systemically administered ketamine and lidocaine on dynamic and static hyperalgesia induced by intradermal capsaicin in humans.
Gottrup H; Hansen PO; Arendt-Nielsen L; Jensen TS
Br J Anaesth; 2000 Feb; 84(2):155-62. PubMed ID: 10743446
[TBL] [Abstract][Full Text] [Related]
10. Postdelivery of alfentanil and ketamine has no effect on intradermal capsaicin-induced pain and hyperalgesia.
Wallace MS; Braun J; Schulteis G
Clin J Pain; 2002; 18(6):373-9. PubMed ID: 12441831
[TBL] [Abstract][Full Text] [Related]
11. Peripheral lidocaine but not ketamine inhibits capsaicin-induced hyperalgesia in humans.
Gottrup H; Bach FW; Arendt-Nielsen L; Jensen TS
Br J Anaesth; 2000 Oct; 85(4):520-8. PubMed ID: 11064608
[TBL] [Abstract][Full Text] [Related]
12. Concentration-effect relationships for intravenous alfentanil and ketamine infusions in human volunteers: effects on acute thresholds and capsaicin-evoked hyperpathia.
Wallace MS; Ridgeway B; Leung A; Schulteis G; Yaksh TL
J Clin Pharmacol; 2002 Jan; 42(1):70-80. PubMed ID: 11808827
[TBL] [Abstract][Full Text] [Related]
13. Low-dose lidocaine reduces secondary hyperalgesia by a central mode of action.
Koppert W; Ostermeier N; Sittl R; Weidner C; Schmelz M
Pain; 2000 Mar; 85(1-2):217-24. PubMed ID: 10692621
[TBL] [Abstract][Full Text] [Related]
14. The effect of ketamine on opioid-induced acute tolerance: can it explain reduction of opioid consumption with ketamine-opioid analgesic combinations?
Kissin I; Bright CA; Bradley EL
Anesth Analg; 2000 Dec; 91(6):1483-8. PubMed ID: 11094005
[TBL] [Abstract][Full Text] [Related]
15. Differential effects of peripheral ketamine and lidocaine on skin flux and hyperalgesia induced by intradermal capsaicin in humans.
Gottrup H; Bach FW; Jensen TS
Clin Physiol Funct Imaging; 2004 Mar; 24(2):103-8. PubMed ID: 15056183
[TBL] [Abstract][Full Text] [Related]
16. The effect of Ketamine on stimulation of primary and secondary hyperalgesic areas induced by capsaicin--a double-blind, placebo-controlled, human experimental study.
Andersen OK; Felsby S; Nicolaisen L; Bjerring P; Jensen TS; Arendt-Nielsen L
Pain; 1996 Jul; 66(1):51-62. PubMed ID: 8857631
[TBL] [Abstract][Full Text] [Related]
17. Different lipid profiles as constituencies of liquid formula diets do not influence pain perception and the efficacy of opioids in a human model of acute pain and hyperalgesia.
Pahl RI; Koppert W; Enk C; Sittl R; Mühldorfer S; Hahn GE; Schmelz M; Schwab D
Pain; 2003 Aug; 104(3):519-527. PubMed ID: 12927624
[TBL] [Abstract][Full Text] [Related]
18. Medial prefrontal cortex activity is predictive for hyperalgesia and pharmacological antihyperalgesia.
Seifert F; Bschorer K; De Col R; Filitz J; Peltz E; Koppert W; Maihöfner C
J Neurosci; 2009 May; 29(19):6167-75. PubMed ID: 19439594
[TBL] [Abstract][Full Text] [Related]
19. Pharmacological modulation of experimental phasic and tonic muscle pain by morphine, alfentanil and ketamine in healthy volunteers.
Schulte H; Graven-Nielsen T; Sollevi A; Jansson Y; Arendt-Nielsen L; Segerdahl M
Acta Anaesthesiol Scand; 2003 Sep; 47(8):1020-30. PubMed ID: 12904196
[TBL] [Abstract][Full Text] [Related]
20. Modulation of remifentanil-induced postinfusion hyperalgesia by propofol.
Singler B; Tröster A; Manering N; Schüttler J; Koppert W
Anesth Analg; 2007 Jun; 104(6):1397-403, table of contents. PubMed ID: 17513631
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
